| Type | Filed | Filer | Subject | Shares Owned | Percent Owned | |
|---|---|---|---|---|---|---|
| SC 13G/A | 2024-04-05 | BlackRock Inc. | scPharmaceuticals Inc. | 1,801,610 | 5.0% | EDGAR |
| SC 13G/A | 2024-02-14 | 5AM Ventures IV, L.P. | scPharmaceuticals Inc. | 980,963 | 2.7% | EDGAR |
| SC 13G/A | 2024-02-14 | ARMISTICE CAPITAL, LLC | scPharmaceuticals Inc. | 0 | 0.0% | EDGAR |
| SC 13G | 2024-02-12 | Rubric Capital Management LP | scPharmaceuticals Inc. | 3,500,000 | 9.8% | EDGAR |
| SC 13G/A | 2024-02-07 | HIRSCHMAN ORIN | scPharmaceuticals Inc. | 3,106,795 | 8.7% | EDGAR |
| SC 13G/A | 2024-02-02 | Cowen Financial Products LLC | scPharmaceuticals Inc. | 0 | 0.0% | EDGAR |
| SC 13G | 2024-02-02 | BlackRock Inc. | scPharmaceuticals Inc. | 1,863,439 | 5.2% | EDGAR |
| SC 13G/A | 2024-01-12 | MILLENNIUM MANAGEMENT LLC | scPharmaceuticals Inc. | 356,873 | 1.0% | EDGAR |
| SC 13G | 2023-03-13 | MILLENNIUM MANAGEMENT LLC | scPharmaceuticals Inc. | 1,722,839 | 5.1% | EDGAR |
| SC 13G | 2023-02-27 | Cowen Financial Products LLC | scPharmaceuticals Inc. | 2,407,562 | 7.1% | EDGAR |
| SC 13G/A | 2023-02-15 | HIRSCHMAN ORIN | scPharmaceuticals Inc. | 2,550,234 | 7.5% | EDGAR |
| SC 13G/A | 2023-02-14 | 5AM Ventures IV, L.P. | scPharmaceuticals Inc. | 2,231,601 | 6.6% | EDGAR |
| SC 13G | 2023-02-14 | ARMISTICE CAPITAL, LLC | scPharmaceuticals Inc. | 2,148,000 | 6.3% | EDGAR |
| SC 13D/A | 2022-11-29 | ORBIMED ADVISORS LLC | scPharmaceuticals Inc. | 5,559,528 | 16.3% | EDGAR |
| SC 13G | 2022-11-25 | HIRSCHMAN ORIN | scPharmaceuticals Inc. | 2,550,234 | 7.5% | EDGAR |
| SC 13G/A | 2022-08-15 | RA CAPITAL MANAGEMENT, L.P. | scPharmaceuticals Inc. | 0 | 0.0% | EDGAR |
| SC 13G/A | 2022-02-18 | RA CAPITAL MANAGEMENT, L.P. | scPharmaceuticals Inc. | 2,691,770 | 9.8% | EDGAR |
| SC 13G/A | 2022-02-14 | RA CAPITAL MANAGEMENT, L.P. | scPharmaceuticals Inc. | 6,691,770 | 9.8% | EDGAR |
| SC 13G/A | 2022-02-14 | Ikarian Capital, LLC | scPharmaceuticals Inc. | 901,362 | 3.3% | EDGAR |
| SC 13G/A | 2021-02-16 | 5AM Ventures IV, L.P. | scPharmaceuticals Inc. | 3,123,303 | 11.4% | EDGAR |